NCT05683951View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of DWKH

PHASE3CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

November 26, 2021

Primary Completion Date

December 9, 2022

Study Completion Date

December 16, 2022

Conditions
Respiratory Infection
Interventions
DRUG

DWKH

Administration of DWKH three times daily

DRUG

DWKH-R

Administration of DWKH-R three times daily

DRUG

Placebo

Administration of Placebo three times daily

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY